EVMN 8-K 2026-07-30

Evommune, Inc. (EVMN) 8-K dated 2026-07-30 — accession 0001193125-26-324972. This URL is the filing, not the EVMN hub.

Evommune, Inc. (EVMN) common stock.

Evommune, Inc. filed a 8-K on 2026-07-30. Accession 0001193125-26-324972.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EVMN revenue for 2025-12-31 was $13.0M. Net income was -$68.9M. Revenue was up 85.7% from 2024-12-31 to 2025-12-31. EVMN currently screens at market cap $0.

Not investment advice. The EVMN SEC hub lists recent forms. The stock page is the research view.